Get started
Author

Christina A. Marsh

mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2012 · Alfredo A. Molinolo, Christina Marsh, et al. · Clinical Cancer Research · 173
Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2011 · Vyomesh Patel, Christina A. Marsh, et al. · Cancer Research · 144
DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays
2012 · Vyomesh Patel, Daniel Martin, et al. · Oral Oncology · 47
PDF
Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome
2012 · Chan Eng Chong, Kue Peng Lim, et al. · Cancer Letters · 32
Stable expression ofShigella dysenteriaeserotype 1 O-antigen genes integrated into the chromosome of liveSalmonellaoral vaccine vector Ty21a
2016 · Madushini N. Dharmasena, Manuel Osorio, et al. · Pathogens and Disease · 15
PDF
Cellular Systems for Studying Human Oral Squamous Cell Carcinomas
2011 · Vyomesh Patel, Ramiro Iglesias-Bartolome, et al. · Advances in experimental medicine and biology · 9
Editor’s Note: mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2025 · Alfredo A. Molinolo, Christina Marsh, et al. · Clinical Cancer Research
PDF
Supplementary Methods and Tables 1 - 2 from mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2023 · Alfredo A. Molinolo, Christina Marsh, et al.
PDF
Data from mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2023 · Alfredo A. Molinolo, Christina Marsh, et al.
Data from mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2023 · Alfredo A. Molinolo, Christina Marsh, et al.
Supplementary Methods and Tables 1 - 2 from mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
2023 · Alfredo A. Molinolo, Christina Marsh, et al.
Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
PDF
Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
PDF
Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
2023 · Vyomesh Patel, Christina A. Marsh, et al.
Abstract LB-7: HPV-associated HNSCC: Widespread mTOR pathway activity and preclinical evaluation of mTOR inhibitors rapamycin and RAD-001
2011 · Christina A. Marsh, Vyomesh Patel, et al. · Cancer Research
Abstract LB-159: An orthotopic model of head and neck squamous carcinoma reveals that mTOR inhibition with rapamycin halts lymph node metastasis
2010 · Christina A. Marsh, Vyomesh Patel, et al. · Cancer Research
Works count: 19
Citation count: 420
H-index: 6
I10-index: 5
Year
Topic
Type